nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—Tonsillitis—Metformin—polycystic ovary syndrome	0.0459	0.133	CcSEcCtD
Montelukast—Sinus headache—Metformin—polycystic ovary syndrome	0.0356	0.103	CcSEcCtD
Montelukast—CYP2C9—urine—polycystic ovary syndrome	0.0162	0.0819	CbGeAlD
Montelukast—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0143	0.0414	CcSEcCtD
Montelukast—Contusion—Metformin—polycystic ovary syndrome	0.0133	0.0385	CcSEcCtD
Montelukast—CYSLTR1—uterus—polycystic ovary syndrome	0.0133	0.0671	CbGeAlD
Montelukast—CYSLTR1—adipose tissue—polycystic ovary syndrome	0.013	0.0656	CbGeAlD
Montelukast—CYP3A4—urine—polycystic ovary syndrome	0.0124	0.0625	CbGeAlD
Montelukast—CYSLTR1—adrenal gland—polycystic ovary syndrome	0.0116	0.0588	CbGeAlD
Montelukast—Neuropathy—Metformin—polycystic ovary syndrome	0.0109	0.0315	CcSEcCtD
Montelukast—CYSLTR1—vagina—polycystic ovary syndrome	0.0108	0.0545	CbGeAlD
Montelukast—CYSLTR1—endocrine gland—polycystic ovary syndrome	0.0101	0.051	CbGeAlD
Montelukast—Ear pain—Metformin—polycystic ovary syndrome	0.00987	0.0285	CcSEcCtD
Montelukast—Injury—Metformin—polycystic ovary syndrome	0.00916	0.0265	CcSEcCtD
Montelukast—ALOX5—adipose tissue—polycystic ovary syndrome	0.00786	0.0397	CbGeAlD
Montelukast—Cramp muscle—Metformin—polycystic ovary syndrome	0.00758	0.0219	CcSEcCtD
Montelukast—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00753	0.0218	CcSEcCtD
Montelukast—Influenza—Metformin—polycystic ovary syndrome	0.00727	0.021	CcSEcCtD
Montelukast—Pancreatitis—Metformin—polycystic ovary syndrome	0.00713	0.0206	CcSEcCtD
Montelukast—ALOX5—adrenal gland—polycystic ovary syndrome	0.00705	0.0356	CbGeAlD
Montelukast—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00693	0.035	CbGeAlD
Montelukast—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00676	0.0196	CcSEcCtD
Montelukast—ALOX5—female gonad—polycystic ovary syndrome	0.00658	0.0332	CbGeAlD
Montelukast—Infestation NOS—Metformin—polycystic ovary syndrome	0.00649	0.0188	CcSEcCtD
Montelukast—Drowsiness—Metformin—polycystic ovary syndrome	0.00649	0.0188	CcSEcCtD
Montelukast—Infestation—Metformin—polycystic ovary syndrome	0.00649	0.0188	CcSEcCtD
Montelukast—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00636	0.0184	CcSEcCtD
Montelukast—SLCO2B1—uterus—polycystic ovary syndrome	0.00619	0.0313	CbGeAlD
Montelukast—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00613	0.0177	CcSEcCtD
Montelukast—ALOX5—endocrine gland—polycystic ovary syndrome	0.00612	0.0309	CbGeAlD
Montelukast—SLCO2B1—adipose tissue—polycystic ovary syndrome	0.00605	0.0306	CbGeAlD
Montelukast—Rhinitis—Metformin—polycystic ovary syndrome	0.00584	0.0169	CcSEcCtD
Montelukast—Hepatitis—Metformin—polycystic ovary syndrome	0.00582	0.0168	CcSEcCtD
Montelukast—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00579	0.0168	CcSEcCtD
Montelukast—CYP2A6—vagina—polycystic ovary syndrome	0.00576	0.0291	CbGeAlD
Montelukast—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00572	0.0166	CcSEcCtD
Montelukast—SLCO2B1—adrenal gland—polycystic ovary syndrome	0.00543	0.0274	CbGeAlD
Montelukast—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0054	0.0156	CcSEcCtD
Montelukast—Immune system disorder—Metformin—polycystic ovary syndrome	0.00526	0.0152	CcSEcCtD
Montelukast—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00525	0.0152	CcSEcCtD
Montelukast—SLCO2B1—female gonad—polycystic ovary syndrome	0.00506	0.0256	CbGeAlD
Montelukast—Muscle spasms—Metformin—polycystic ovary syndrome	0.00487	0.0141	CcSEcCtD
Montelukast—Tremor—Metformin—polycystic ovary syndrome	0.00475	0.0137	CcSEcCtD
Montelukast—SLCO2B1—endocrine gland—polycystic ovary syndrome	0.00471	0.0238	CbGeAlD
Montelukast—Palpitations—Metformin—polycystic ovary syndrome	0.00448	0.013	CcSEcCtD
Montelukast—CYP2C8—endometrium—polycystic ovary syndrome	0.00432	0.0218	CbGeAlD
Montelukast—Myalgia—Metformin—polycystic ovary syndrome	0.00432	0.0125	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00429	0.0124	CcSEcCtD
Montelukast—Oedema—Metformin—polycystic ovary syndrome	0.00414	0.012	CcSEcCtD
Montelukast—Infection—Metformin—polycystic ovary syndrome	0.00411	0.0119	CcSEcCtD
Montelukast—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00406	0.0117	CcSEcCtD
Montelukast—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00405	0.0117	CcSEcCtD
Montelukast—Skin disorder—Metformin—polycystic ovary syndrome	0.00402	0.0116	CcSEcCtD
Montelukast—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00391	0.0197	CbGeAlD
Montelukast—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00377	0.0109	CcSEcCtD
Montelukast—Paraesthesia—Metformin—polycystic ovary syndrome	0.00371	0.0107	CcSEcCtD
Montelukast—Somnolence—Metformin—polycystic ovary syndrome	0.00368	0.0106	CcSEcCtD
Montelukast—Dyspepsia—Metformin—polycystic ovary syndrome	0.00364	0.0105	CcSEcCtD
Montelukast—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00357	0.0103	CcSEcCtD
Montelukast—Fatigue—Metformin—polycystic ovary syndrome	0.00357	0.0103	CcSEcCtD
Montelukast—PTGS1—endometrium—polycystic ovary syndrome	0.0035	0.0177	CbGeAlD
Montelukast—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00338	0.00979	CcSEcCtD
Montelukast—Urticaria—Metformin—polycystic ovary syndrome	0.00329	0.00951	CcSEcCtD
Montelukast—Abdominal pain—Metformin—polycystic ovary syndrome	0.00327	0.00946	CcSEcCtD
Montelukast—CYP2C8—vagina—polycystic ovary syndrome	0.00324	0.0163	CbGeAlD
Montelukast—PTGS1—uterus—polycystic ovary syndrome	0.00323	0.0163	CbGeAlD
Montelukast—PTGS1—pituitary gland—polycystic ovary syndrome	0.00317	0.016	CbGeAlD
Montelukast—PTGS1—adipose tissue—polycystic ovary syndrome	0.00316	0.0159	CbGeAlD
Montelukast—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00303	0.0153	CbGeAlD
Montelukast—Asthenia—Metformin—polycystic ovary syndrome	0.00297	0.00859	CcSEcCtD
Montelukast—Pruritus—Metformin—polycystic ovary syndrome	0.00293	0.00847	CcSEcCtD
Montelukast—PTGS1—adrenal gland—polycystic ovary syndrome	0.00283	0.0143	CbGeAlD
Montelukast—Diarrhoea—Metformin—polycystic ovary syndrome	0.00283	0.00819	CcSEcCtD
Montelukast—Dizziness—Metformin—polycystic ovary syndrome	0.00274	0.00792	CcSEcCtD
Montelukast—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00269	0.0136	CbGeAlD
Montelukast—PTGS1—female gonad—polycystic ovary syndrome	0.00264	0.0133	CbGeAlD
Montelukast—Vomiting—Metformin—polycystic ovary syndrome	0.00263	0.00761	CcSEcCtD
Montelukast—PTGS1—vagina—polycystic ovary syndrome	0.00262	0.0133	CbGeAlD
Montelukast—Rash—Metformin—polycystic ovary syndrome	0.00261	0.00755	CcSEcCtD
Montelukast—Dermatitis—Metformin—polycystic ovary syndrome	0.00261	0.00754	CcSEcCtD
Montelukast—Headache—Metformin—polycystic ovary syndrome	0.00259	0.0075	CcSEcCtD
Montelukast—Nausea—Metformin—polycystic ovary syndrome	0.00246	0.00711	CcSEcCtD
Montelukast—PTGS1—endocrine gland—polycystic ovary syndrome	0.00246	0.0124	CbGeAlD
Montelukast—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00205	0.0104	CbGeAlD
Montelukast—ALOX5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000279	0.000611	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000277	0.000607	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000277	0.000607	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000277	0.000607	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000274	0.0006	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000274	0.000599	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000273	0.000598	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000272	0.000595	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000271	0.000594	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00027	0.000591	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000267	0.000585	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000267	0.000584	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000267	0.000584	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000264	0.000578	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000263	0.000577	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000259	0.000568	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000257	0.000564	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000257	0.000564	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000256	0.000562	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000252	0.000553	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TEAD2—polycystic ovary syndrome	0.000252	0.000553	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000252	0.000553	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000252	0.000552	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00025	0.000548	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000249	0.000546	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000248	0.000544	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000246	0.000538	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000245	0.000537	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000242	0.00053	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00024	0.000525	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000239	0.000523	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000238	0.000522	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.000238	0.000522	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000232	0.000509	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000228	0.0005	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000228	0.0005	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000227	0.000498	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000227	0.000497	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000225	0.000494	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000225	0.000493	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000225	0.000492	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TH—polycystic ovary syndrome	0.000224	0.000492	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000224	0.00049	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000222	0.000487	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000221	0.000483	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SLC2A4—polycystic ovary syndrome	0.000218	0.000478	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.000218	0.000478	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.000218	0.000478	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000217	0.000477	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000217	0.000474	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000215	0.000472	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000213	0.000467	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000212	0.000464	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000211	0.000463	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP19A1—polycystic ovary syndrome	0.000205	0.00045	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000204	0.000447	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000203	0.000445	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.000203	0.000444	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000202	0.000443	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.000202	0.000443	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SRD5A1—polycystic ovary syndrome	0.0002	0.000439	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.0002	0.000438	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000198	0.000434	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000198	0.000433	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000194	0.000425	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—STAR—polycystic ovary syndrome	0.000191	0.000419	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000188	0.000413	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000185	0.000405	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000185	0.000405	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000185	0.000405	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GNAS—polycystic ovary syndrome	0.000183	0.000401	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000181	0.000396	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00018	0.000395	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.00018	0.000395	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000178	0.00039	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000177	0.000389	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000177	0.000389	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000175	0.000384	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000175	0.000384	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NCOR1—polycystic ovary syndrome	0.000175	0.000382	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.000172	0.000378	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.000172	0.000378	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000172	0.000377	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMMR—polycystic ovary syndrome	0.00017	0.000373	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00017	0.000372	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000166	0.000363	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP1A1—polycystic ovary syndrome	0.000165	0.000362	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000165	0.000361	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000164	0.00036	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000163	0.000357	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000163	0.000356	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000161	0.000353	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000161	0.000353	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000158	0.000347	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000157	0.000343	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000155	0.000339	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MTHFR—polycystic ovary syndrome	0.000154	0.000338	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000153	0.000336	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00015	0.00033	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000148	0.000325	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	0.000148	0.000325	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000145	0.000319	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000145	0.000317	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000144	0.000316	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000143	0.000314	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000143	0.000313	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00014	0.000307	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.00014	0.000307	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.00014	0.000307	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000138	0.000303	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000137	0.0003	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.000299	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000135	0.000295	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000133	0.000292	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000133	0.000291	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—INS—polycystic ovary syndrome	0.000132	0.00029	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000132	0.00029	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000131	0.000286	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000129	0.000283	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000129	0.000283	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000128	0.00028	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000128	0.00028	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000128	0.00028	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000127	0.000279	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—polycystic ovary syndrome	0.000125	0.000274	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	0.000125	0.000274	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—POMC—polycystic ovary syndrome	0.000123	0.00027	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—INS—polycystic ovary syndrome	0.000123	0.000269	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000122	0.000268	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000122	0.000267	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000122	0.000266	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000121	0.000265	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	0.000121	0.000264	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00012	0.000263	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000118	0.000257	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000117	0.000256	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000117	0.000256	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000116	0.000255	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	0.000116	0.000254	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000114	0.000251	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000114	0.00025	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000112	0.000246	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000111	0.000244	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000111	0.000243	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00011	0.00024	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000109	0.000238	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000108	0.000238	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000108	0.000237	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000106	0.000233	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000106	0.000233	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000105	0.00023	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000104	0.000228	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000101	0.000222	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	9.9e-05	0.000217	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.79e-05	0.000214	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TH—polycystic ovary syndrome	9.73e-05	0.000213	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	9.58e-05	0.00021	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	9.47e-05	0.000208	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	9.46e-05	0.000207	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	9.25e-05	0.000203	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	9.25e-05	0.000203	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TH—polycystic ovary syndrome	9.2e-05	0.000202	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	9.04e-05	0.000198	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	8.95e-05	0.000196	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.93e-05	0.000196	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	8.9e-05	0.000195	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	8.82e-05	0.000193	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	8.54e-05	0.000187	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.47e-05	0.000186	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	8.42e-05	0.000184	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.36e-05	0.000183	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	8.24e-05	0.000181	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	8.23e-05	0.00018	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	8.05e-05	0.000176	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	7.94e-05	0.000174	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.91e-05	0.000173	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.87e-05	0.000172	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.81e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.8e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.76e-05	0.00017	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.75e-05	0.00017	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	7.57e-05	0.000166	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	7.51e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	7.38e-05	0.000162	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.35e-05	0.000161	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	7.26e-05	0.000159	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	7.18e-05	0.000157	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	7.17e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	7.16e-05	0.000157	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	7.01e-05	0.000154	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.95e-05	0.000152	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	6.78e-05	0.000149	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.7e-05	0.000147	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	6.69e-05	0.000147	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.44e-05	0.000141	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.4e-05	0.00014	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	6.36e-05	0.000139	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	6.32e-05	0.000139	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.31e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TH—polycystic ovary syndrome	6.28e-05	0.000138	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.25e-05	0.000137	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	6.11e-05	0.000134	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	6e-05	0.000132	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.96e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.91e-05	0.00013	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—polycystic ovary syndrome	5.78e-05	0.000127	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.75e-05	0.000126	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.43e-05	0.000119	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	5.42e-05	0.000119	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—polycystic ovary syndrome	5.35e-05	0.000117	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INS—polycystic ovary syndrome	5.32e-05	0.000117	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.31e-05	0.000116	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.14e-05	0.000113	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	5.13e-05	0.000112	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	5.13e-05	0.000112	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.11e-05	0.000112	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	5.06e-05	0.000111	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INS—polycystic ovary syndrome	5.03e-05	0.00011	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.98e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.89e-05	0.000107	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.73e-05	0.000104	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.68e-05	0.000103	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.63e-05	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.59e-05	0.0001	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.42e-05	9.68e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.32e-05	9.46e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.25e-05	9.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.19e-05	9.19e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.18e-05	9.15e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.98e-05	8.72e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.96e-05	8.68e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.9e-05	8.54e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.77e-05	8.26e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.52e-05	7.7e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.5e-05	7.67e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.45e-05	7.57e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.44e-05	7.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.37e-05	7.39e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.28e-05	7.19e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.09e-05	6.76e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.85e-05	6.25e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.81e-05	6.16e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.8e-05	6.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.75e-05	6.03e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.62e-05	5.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.49e-05	5.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.32e-05	5.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.88e-05	4.12e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.85e-05	4.06e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.84e-05	4.04e-05	CbGpPWpGaD
